PE-backed Tabula Rasa buys SinfoníaRx

Tabula Rasa Healthcare has acquired SinfoníaRx, a provider of medication therapy management technology and services for Medicare, Medicaid and commercial health plans. No financial terms were disclosed. Signal Hill advised SinfoníaRx on the transaction. Tabula Rasa’s backers included Originate Ventures, Radius Ventures and Emerald Stage2 Ventures.

North AmericaUSM&A DealsBriefs